The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI (NCT06892275)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) decision support (enhanced usual care + decision aid). Assessments will take place at baseline (T0) and 1-month post-intervention (T1). The primary outcome is informed decisions about breast MRI at T1.
Who can join: Review the eligibility criteria below.
Location: Georgetown University — Washington D.C., District of Columbia
Age range: 18 Years to 74 Years
🧪 Interventions in This Study
- Enhanced Usual Care (BEHAVIORAL)
- Decision Support (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Georgetown University — Washington D.C., District of Columbia
📞 Contact the Study Coordinator
Phone: (202) 687-5086
Email: claire.conley@georgetown.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Breast Neoplasm Female
- Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients — New York, New York
- RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy — St Louis, Missouri
- A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2) — Darlinghurst, New South Wales
- Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response — Iowa City, Iowa
Explore by condition: All Breast Neoplasm Female clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.